Mumps Vaccine

Mumps Vaccine is a freeze dried preparation containing a suitable live attenuated strain of mumps virus grown in a cultures of human diploid cells or chick embryo cells or the amniotic cavity of chick embryos. Mumps Vaccine is used to provide active immunization against mumps. Mumps Vaccine is recommended for children 12 month of age and older and adults.


Adult Dose
Dose: 0.5 ml
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: IM,SC
Instructions: Once or As Required
Neonatal
Dose: Not indicated below one year of children
Single Dose:
Frequency:
Route:
Instructions:
Paedriatic
Dose: 0.5 ml
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Intra Muscular
Instructions: Once or as required , in Children over 1 Year of Age
Characteristics
. It is of Natural origin. It belongs to Toxoids and Vaccines pharmacological group.
Contraindications
Mumps Vaccine is contraindicated in conditions like Pregnancy,Febrile illness,Hypersensitivity to any component of product.
Effects
The severe or irreversible adverse effects of Mumps Vaccine, which give rise to further complications include Encephalitis, Meningitis, Nerve deafness.The symptomatic adverse reactions produced by Mumps Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Parotid swelling.
Indications
Mumps Vaccine is primarily indicated in conditions like Mumps prevention.
Interactions
Mumps Vaccine is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAzathioprineConcurrent use may weaken the immune system.Cyclosporin AConcurrent use may weaken the immune system.Immune GlobulinAdministration of immune globulins concurrently with Mumps Vaccine may interfere with the expected immune response.LeflunomideConcurrent use may weaken the immune system.Muromonab-cd3Concurrent use may weaken the immune system.PentostatinConcurrent use may potentiate a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.MajorIn general, live virus or bacterial vaccines should not be used in patients receiving immunosuppressive therapy or cancer chemotherapy. Vaccination should be deferred until after such therapy is discontinued for at least 3 months in most cases.RituximabThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.MajorThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.TacrolimusConcurrent use may weaken the immune system. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
Drug should not be given to Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
SC Inj Store in refrigerator. Protect from Sunlight.
Warnings
Vaccine should be used only if clearly needed during pregnancy. It should be used with caution in patients with any pre-existing infection, blood disorders, tumors, bone marrow disease, tuberculosis, history of seizure disorder or any allergy, especially to eggs or neomycin antibiotic.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.